50
Participants
Start Date
December 6, 2012
Primary Completion Date
October 22, 2015
Study Completion Date
January 29, 2018
EVG/COBI/FTC/TDF
150/150/200/300 mg STR administered orally once daily with food
Perinatal HIV Research Unit, Soweto
Clinical HIV Research Unit, Johannesburg
Rahima Moosa Mother and Child Hospital (Wits), Johannesburg
Mpati Medical Center, Dundee
Dr Latiff Private Practice, Durban
University of Stellenbosch, Stellenbosch
Desmond Tutu HIV Research Centre, Cape Town
New York University School of Medicine, New York
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok
Montefiore Medical Center, The Bronx
Siriraj Hospital, Mahidol University, Bangkok
St. Christopher's Hospital for Children, Philadelphia
Queen Savang Vadhana Memorial Hospital, Chon Buri
University of South Florida - Department of Pediatrics, Tampa
St. Jude Children's Research Hospital, Memphis
Srinakarind Hospital, Khon Kaen
University of Chicago, Chicago
East Bay AIDS Center Medical Group, Oakland
Lead Sponsor
Gilead Sciences
INDUSTRY